Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reporting Adverse Events Found Online Complicated By Internet's Anonymity; Can Widgets Rescue Industry From Compliance Conundrums?

Executive Summary

FDA should modify its adverse event reporting policy to allow protection of patient privacy for AEs that sponsors discover online, industry representatives told the agency during its two-day public meeting on regulation of the Internet

You may also be interested in...



Get Moving On Social Media, But Carefully, Attorneys And Marketers Say

While many medical device and drug companies fear delving into social media without clear guidance from FDA, speakers at the Food & Drug Law Institute's 2010 annual conference advised companies to move ahead on their own, but with caution

Get Moving On Social Media, But Carefully, Attorneys And Marketers Say

While many medical device and drug companies fear delving into social media without clear guidance from FDA, speakers at the Food & Drug Law Institute's 2010 annual conference advised companies to move ahead on their own, but with caution

Year In Review: FDA Spotlights Social Media, But No Guidelines Yet

As drug makers await feedback from FDA on the use of the Internet and newer technologies for drug promotion, more are warming to the idea that unbranded campaigns in these media are the safest bet, for now

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel